Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COSTA: HCQ + Camostat vs HCQ + Azithromycin in COVID-19
NCT04355052Phase 3Unknown
- Sponsor
- Sheba Medical Center
- Start
- Apr 2020
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Sheba Medical Center. Status: unknown.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04355052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355052.